NEXGEN CANCER DETECTION LLC

Medtech · Private

Blood-based cancer detection assay that selectively amplifies circulating tumor DNA while blocking normal DNA replication to identify residual cancer from a single blood draw

Grants
$1.5M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
8
1 granted · 7 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I:Enrichment of Cancer DNA for Improved Cancer Diagnostics from Blood$275,000
Federal grantNational Science Foundation · Phase II · SBIR Phase II: Enrichment of Cancer DNA for Improved Cancer Diagnostics from Blood$1,250,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1619EVIZIA INC——
1620PHOTOSONOX LLC——
1621Champaign Imaging LLC——
1622NEXGEN CANCER DETECTION LLC——
1623WetWare BioSystems LLC——
1624Thrive Health Tech, Inc.—$5.0M
1625FLXION MEDICAL, INC.—$21K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 8
  • Methods For Enriching A Target Polynucleotide In A Samplegranted
  • Methods For Detecting A Target Polynucleotide In A Sampleapplication
  • Methods For Enriching And Detecting A Target Polynucleotide In A Sampleapplication
  • Methods For Detecting A Target Polynucleotide In A Sample Comprising A Mixture Of The Target Polynucleotide And A Non-target Polynucleotideapplication
  • Diagnostic applications using variant enrich nucleic acidsapplication
  • Improvement To Methods For Enriching And Detecting A Target Polynucleotide In A Sampleapplication
  • Methods For Enriching And Detecting A Target Polynucleotide In A Sampleapplication
  • Methods For Enriching And Detecting A Target Polynucleotide In A Sampleapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.